Publications

Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

Questions and answers on regulatory expectations for medicinal products for human use during the COVID-19 pandemic

10 April 2020

External Resource

Open

Position Paper. Incentives Review The Orphan and Paediatric Incentives

1 March 2020

Policy

Open

Why is Now the Right Time to Modernise the Eu Variations System?

30 January 2020

Report

Open

AMR Industry Alliance 2020 Progress Report

16 January 2020

Report

Open

Perceptions and recommendations of physicians/KOLs on value added medicines

21 November 2019

Report

Open

The secret to improve access to value added medicines

14 November 2019

Policy

Open

Overarching recommendations for improved access to generic and biosimilar medicines in the hospital setting

7 October 2019

Report

Open

Improving healthcare delivery in hospitals by optimized utilization of medicines

7 October 2019

Report

Open

A digital future for value added medicines

24 September 2019

Policy, Report

Open

Open letter to the Members of the European Parliament on the importance to sustain EU progress in fighting against antimicrobial resistance (AMR)

11 September 2019

Policy

Open

Subscribe to our newsletter